![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/12 | |
A61K 9/08 | |||
A61K 31/4178 | |||
A61K 31/439 | |||
A61K 31/45 | |||
A61K 31/4709 | |||
A61P 1/08 | |||
A61P 17/00 | |||
A61P 25/04 | |||
A61P 25/16 | |||
A61P 25/24 | |||
A61P 25/28 | |||
A61P 43/00 |
(11) | Number of the document | 2887962 |
(13) | Kind of document | T |
(96) | European patent application number | 13759080.8 |
Date of filing the European patent application | 2013-08-23 | |
(97) | Date of publication of the European application | 2015-07-01 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/056391 |
Date | 2013-08-23 |
(87) | Number | WO 2014/031958 |
Date | 2014-02-27 |
(30) | Number | Date | Country code |
201261693135 P | 2012-08-24 | US | |
201361777276 P | 2013-03-12 | US |
(72) |
VALIA, Kirti, H., US
KYDONIEUS, Agis, US
|
(73) |
Integurx Therapeutics LLC,
14 Laurel Mountain Way, Califon, NJ 07830,
US
|
(54) | CHEMICAL COMPOSITIONS AND METHODS FOR ENHANCING TRANSDERMAL DELIVERY OF THERAPEUTIC AGENTS |
CHEMICAL COMPOSITIONS AND METHODS FOR ENHANCING TRANSDERMAL DELIVERY OF THERAPEUTIC AGENTS |